Rezolute Change To Netincome Over Time
| RZLT Stock | USD 4.58 0.06 1.29% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Rezolute Performance and Rezolute Correlation. Rezolute |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rezolute. If investors know Rezolute will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rezolute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.34) | Return On Equity (0.58) |
The market value of Rezolute is measured differently than its book value, which is the value of Rezolute that is recorded on the company's balance sheet. Investors also form their own opinion of Rezolute's value that differs from its market value or its book value, called intrinsic value, which is Rezolute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rezolute's market value can be influenced by many factors that don't directly affect Rezolute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rezolute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rezolute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rezolute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Change To Netincome Analysis
Compare Rezolute and related stocks such as Puma Biotechnology, Iovance Biotherapeutics, and Day One Biopharmaceu Change To Netincome Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBYI | 8.1 M | 8.1 M | 20.1 M | 7.5 M | 39.3 M | 95.1 M | 117.6 M | 108.7 M | 87.2 M | 66.6 M | 37.6 M | 39.8 M | 18.8 M | 21.7 M | 20.6 M |
| IOVA | 2.5 M | 2.5 M | (5.3 M) | 1 M | 3.8 M | 8.5 M | 18.9 M | 12 M | 20 M | 24 M | 40.9 M | 69.8 M | 84.9 M | 97.6 M | 102.5 M |
| DAWN | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 27.2 M | 13.3 M | 27.2 M | 31.3 M | 20.8 M |
| INZY | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | 230 K | 20.3 M | 7.7 M | 7.7 M | 8.8 M | 7 M |
| ZNTL | 308 K | 308 K | 308 K | 308 K | 308 K | 308 K | 308 K | 308 K | 308 K | (98 K) | 23 M | 46.4 M | 62.4 M | 71.8 M | 75.4 M |
| SNDX | 510 K | 510 K | 510 K | 510 K | 510 K | 6.3 M | 6.3 M | 5.7 M | 6.2 M | 6 M | 9.4 M | 12.9 M | 14 M | 16.1 M | 8.2 M |
| PTGX | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 174 K | 7 M | 4.9 M | 6.9 M | 8.4 M | 8.5 M | 18.1 M | 24.2 M | 27.8 M | 29.2 M |
Rezolute and related stocks such as Puma Biotechnology, Iovance Biotherapeutics, and Day One Biopharmaceu Change To Netincome description
My Equities
My Current Equities and Potential Positions
| Rezolute | RZLT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 4.58
Additional Tools for Rezolute Stock Analysis
When running Rezolute's price analysis, check to measure Rezolute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rezolute is operating at the current time. Most of Rezolute's value examination focuses on studying past and present price action to predict the probability of Rezolute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rezolute's price. Additionally, you may evaluate how the addition of Rezolute to your portfolios can decrease your overall portfolio volatility.